204 related articles for article (PubMed ID: 21088574)
1. Is there an obesity-metabolic syndrome related glomerulopathy?
Ritz E; Koleganova N; Piecha G
Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):44-9. PubMed ID: 21088574
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and kidney disease.
Ritz E
Blood Purif; 2008; 26(1):59-62. PubMed ID: 18182798
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.
Darouich S; Goucha R; Jaafoura MH; Zekri S; Ben Maiz H; Kheder A
Ultrastruct Pathol; 2011 Aug; 35(4):176-82. PubMed ID: 21657818
[TBL] [Abstract][Full Text] [Related]
4. Renal disease in obesity: the need for greater attention.
Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
[TBL] [Abstract][Full Text] [Related]
5. Structural renal changes in obesity and diabetes.
Amann K; Benz K
Semin Nephrol; 2013 Jan; 33(1):23-33. PubMed ID: 23374891
[TBL] [Abstract][Full Text] [Related]
6. Focal segmental glomerulosclerosis after renal transplantation.
Shimizu A; Higo S; Fujita E; Mii A; Kaneko T
Clin Transplant; 2011 Jul; 25 Suppl 23():6-14. PubMed ID: 21623907
[TBL] [Abstract][Full Text] [Related]
7. Obesity and chronic kidney disease.
Eknoyan G
Nefrologia; 2011; 31(4):397-403. PubMed ID: 21623393
[TBL] [Abstract][Full Text] [Related]
8. Obesity-related glomerulopathy: an emerging epidemic.
Kambham N; Markowitz GS; Valeri AM; Lin J; D'Agati VD
Kidney Int; 2001 Apr; 59(4):1498-509. PubMed ID: 11260414
[TBL] [Abstract][Full Text] [Related]
9. Focal segmental glomerulosclerosis and renal transplantation.
Crosson JT
Transplant Proc; 2007 Apr; 39(3):737-43. PubMed ID: 17445586
[TBL] [Abstract][Full Text] [Related]
10. [Obesity and chronic kidney disease].
Bondar' IA; Klimontov VV; Simakova AI
Ter Arkh; 2011; 83(6):66-70. PubMed ID: 21786579
[TBL] [Abstract][Full Text] [Related]
11. Morphometric and immunohistochemical insight into focal segmental glomerulosclerosis in obese and non-obese patients.
Danilewicz M; Wagrowska-Danielwicz M
Nefrologia; 2009; 29(1):35-41. PubMed ID: 19240770
[TBL] [Abstract][Full Text] [Related]
12. Secondary focal segmental glomerulosclerosis in non-obese patients with increased muscle mass.
Schwimmer JA; Markowitz GS; Valeri AM; Imbriano LJ; Alvis R; D'Agati VD
Clin Nephrol; 2003 Oct; 60(4):233-41. PubMed ID: 14579937
[TBL] [Abstract][Full Text] [Related]
13. The Fatty Kidney: Obesity and Renal Disease.
Praga M; Morales E
Nephron; 2017; 136(4):273-276. PubMed ID: 27414023
[TBL] [Abstract][Full Text] [Related]
14. [Overweight and obesity--risk factors in the development and progression of renal disease].
Sebeková K; Klassen A; Bahner U; Heidland A
Vnitr Lek; 2004 Jul; 50(7):544-9. PubMed ID: 15323263
[TBL] [Abstract][Full Text] [Related]
15. New players in the pathogenesis of focal segmental glomerulosclerosis.
Schell C; Huber TB
Nephrol Dial Transplant; 2012 Sep; 27(9):3406-12. PubMed ID: 22767631
[TBL] [Abstract][Full Text] [Related]
16. Renal consequences of obesity.
Naumnik B; Myśliwiec M
Med Sci Monit; 2010 Aug; 16(8):RA163-70. PubMed ID: 20671624
[TBL] [Abstract][Full Text] [Related]
17. [Renal consequences of obesity].
Laville M
Nephrol Ther; 2011 Apr; 7(2):80-5. PubMed ID: 21208837
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid receptor activation in obesity hypertension.
Nagase M; Fujita T
Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
[TBL] [Abstract][Full Text] [Related]
19. Effects of genetic obesity on renal structure and function in the Zucker rat.
Kasiske BL; Cleary MP; O'Donnell MP; Keane WF
J Lab Clin Med; 1985 Nov; 106(5):598-604. PubMed ID: 4056570
[TBL] [Abstract][Full Text] [Related]
20. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
Wahba IM; Mak RH
Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
